Allgenesis Biotherapeutics Inc. v. Cloudbreak Therapeutics, LLC addresses whether an IPR petitioner can assert Article III standing on appeal based on potential infringement liability and potential preclusive effects on its patents.Continue Reading Petitioner Failed to Establish Standing in IPR Appeal
In Apple Inc. v. Corephotonics, LTD., the court addressed two final written decisions in inter partes review (“IPR”) proceedings and in particular (1) whether the Patent Trial and Appeal Board’s (“PTAB” or “Board”) claim construction is correct when the intrinsic evidence supports a different construction and relatedly whether the PTAB’s first final written decision relying on its claim construction should be vacated and remanded and (2) whether, in the second final written decision, the PTAB’s reliance on an invalidity ground not raised by any party should be vacated and remanded.Continue Reading Federal Circuit Vacates PTAB’s Decision Based on an Overly Narrow Claim Construction
This case addresses whether attorney’s fees are warranted due to an inequitable conduct and conflict of interest defense.Continue Reading United Cannabis Corporation v. Pure Hemp Collective Inc.
This case addresses the issue of res judicata and the interpretation of the scope of an earlier judgment awarding an ongoing royalty.Continue Reading Inguran, LLC, DBA STGenetics V. ABS Global, INC., Genius PLC, No. 2022-1385 (July 5, 2023)
We are excited to share Sheppard Mullin’s inaugural quarterly report on key Federal Circuit decisions. The Spring 2023 Quarterly Report provides summaries of most key patent law-related decisions from January 1, 2023 to March 31, 2023.Continue Reading 2023 Federal Circuit Case Summaries